Harinath Chakrapani

Title: Harinath Chakrapani: Innovator in Cancer Treatment

Introduction

Harinath Chakrapani is a notable inventor based in Pashan, Pune, India. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. His work focuses on developing methods and compounds that enhance the effectiveness of cancer therapies.

Latest Patents

Harinath Chakrapani holds a patent for diazeniumdiolated compounds, pharmaceutical compositions, and methods of treating cancer. The patent discloses a method of treating cancer in a patient by administering an effective amount of a diazeniumdiolated (NO-containing) compound or a pharmaceutically acceptable salt thereof. This method targets cancer cells that exhibit elevated levels of reactive oxygen species (ROS) and/or decreased levels of specific proteins compared to normal cells. The patent also includes details on enhancing chemotherapeutic treatments with these compounds.

Career Highlights

Chakrapani is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this prestigious institution allows him to contribute to groundbreaking research in the medical field, particularly in oncology.

Collaborations

Harinath Chakrapani has collaborated with esteemed colleagues, including Anna E Maciag and Larry K Keefer. These collaborations have furthered his research and development efforts in cancer treatment.

Conclusion

Harinath Chakrapani's innovative work in developing diazeniumdiolated compounds represents a significant advancement in cancer treatment methodologies. His contributions continue to impact the field positively, offering hope for improved therapeutic options for patients.